Literature DB >> 30104063

Long-term results of the modified Konno procedure in high-risk children with obstructive hypertrophic cardiomyopathy.

Mikael Laredo1, Diala Khraiche2, Olivier Raisky2, Régis Gaudin2, Fanny Bajolle2, Alice Maltret2, Sylvie Chevret3, Damien Bonnet2, Pascal R Vouhé2.   

Abstract

OBJECTIVE: Transaortic septal myectomy is the gold standard surgery in obstructive hypertrophic cardiomyopathy, but it is not optimal for children aged less than 5 years and with right ventricular outflow tract obstruction. We evaluated outcomes with the modified Konno procedure in children with severe forms of obstructive hypertrophic cardiomyopathy.
METHODS: A total of 79 consecutive children who underwent the modified Konno procedure in our center between 1991 and 2016 were included.
RESULTS: Clinical features included age less than 5 years (38%), maximal septal thickness 25 mm or more (32%), extension to the left ventricular apex (29%), and right ventricular outflow tract obstruction (28%). In total, 25% of patients had Noonan syndrome. Five children (6%) aged less than 15 months with Noonan syndrome and biventricular obstruction died in the hospital. Mean follow-up was 6 ± 5.7 years. Survival without death and heart transplantation was 82% at 20 years. Atrioventricular block occurred in 9 patients (11%) and was associated with right ventricular outflow tract obstruction and surgery before 2010. Death, resuscitated sudden cardiac death, and appropriate implantable defibrillator shock were associated with maximal septal thickness before surgery (adjusted odds ratio, 1.20; 95% confidence interval, 1.07-1.35; P = .002) and need for an associated procedure (adjusted odds ratio, 8.84; 95% confidence interval, 2.01-38.93; P = .004). There was no case of recurrent obstruction. Reoperation was required in 4 patients (5%) for other reasons.
CONCLUSIONS: The modified Konno procedure provided durable obstruction relief and good long-term survival in children with severe forms of obstructive hypertrophic cardiomyopathy. Children with Noonan syndrome undergoing surgery early in life were at higher risk of early mortality.
Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Noonan syndrome; hypertrophic cardiomyopathy; implantable cardioverter-defibrillator; pediatrics; right ventricular outflow tract obstruction; septal myectomy

Mesh:

Year:  2018        PMID: 30104063     DOI: 10.1016/j.jtcvs.2018.06.040

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Mitral valve replacement and trans-mitral myectomy for a child with Noonan syndrome accompanied by hypertrophic obstructive cardiomyopathy.

Authors:  Takashi Sasaki; Toshihide Asou; Makoto Shirakawa; Ken-Ichiro Takahashi; Shinobu Kunugi; Takashi Nitta
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-02-19

2.  Pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: the multifaceted consequences of PTPN11 mutations.

Authors:  Giulio Calcagni; Maria Cristina Digilio; Bruno Marino; Marco Tartaglia
Journal:  Orphanet J Rare Dis       Date:  2019-07-05       Impact factor: 4.123

3.  Management of Complex Left Ventricular Outflow Tract Obstruction: A Comparison of Konno and Modified Konno Techniques.

Authors:  Mahwish Haider; Laura Carlson; Hua Liu; Christopher Baird; John E Mayer; Meena Nathan
Journal:  Pediatr Cardiol       Date:  2021-02-08       Impact factor: 1.655

4.  Endocardial Radiofrequency Ablation vs. Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis.

Authors:  Tao Jiang; Bingyu Huang; Shengqi Huo; Lulu Monica Mageta; Junyi Guo; Jiagao Lv; Li Lin
Journal:  Front Surg       Date:  2022-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.